Mikko Loukovaara

Mikko Loukovaara serves as an Adjunct Professor at the University of Helsinki's Faculty of Medicine, Department of Obstetrics and Gynecology, with clinical affiliation at HUS Gynecology and Obstetrics. He supervises doctoral candidates in the Clinical Research Programme, guiding advanced studies in gynecologic oncology and molecular pathology.

His research centers on endometrial cancer molecular subtyping, investigating mismatch repair deficiency, HER2 status, and clinicopathological correlations to refine prognostic models. Key interests include lymphovascular space invasion quantification, molecular subgroup-specific survival analysis, and risk stratification systems for endometrial carcinoma classification.

Recent publications (2024-2025) demonstrate consistent focus on molecular classification frameworks using large cohort studies. His work integrates European guidelines with FIGO staging to evaluate clinical outcomes across molecular subgroups, particularly in relapsed and early-stage endometrioid carcinomas.

As a doctoral supervisor, Dr. Loukovaara mentors clinical researchers in translational oncology projects. He recently collaborated on the 2024 study optimizing oral cancer medication pathways from hospital to home care, reflecting his engagement in practical clinical implementation research.